Protocols of conversion from cyclosporin A ( CsA ) to sirolimus ( SRL ) have been widely used in immunotherapy after transplantation to prevent CsA-induced nephropathy , but the molecular mechanisms underlying these protocols remain nuclear .
O O O O B-ChemicalEntity I-ChemicalEntity O B-ChemicalEntity O O B-ChemicalEntity O B-ChemicalEntity O O O O O O O O O O O B-ChemicalEntity B-DiseaseOrPhenotypicFeature O O O O O O O O O O O